Araris Biotech AG Expands its IP Portfolio with the Acquisition of Innate Pharma’s Portfolio of...

AstraZeneca, Daiichi Sankyo’s ADC Flops in Phase III Breast Cancer on Heels of Lung Cancer...

Innate Pharma Announces FDA Clearance of the IND for IPH4502, a Nectin-4 ADC to Be...

Pinotbio Secures Milestone Payment Following Celltrion’s Execution of ADC Platform Technology Option

FDA Grants Fast Track Status to EO-3021 for CLDN18.2-Expressing Gastric or GEJ Cancer